Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of G201-Na capsules in women undergoing ART for controlled ovarian hyperstimulation
CTR20254476Phase 2Active
- Sponsor
- Yiling Pharmaceutical
- Start
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of G201-Na in infertility (3 arms), sponsored by Yiling Pharmaceutical. Primary endpoint: Suppression rate of premature LH surge. Started Apr 2026; status: active.
02
Drugs
G201-Na
03
Conditions
infertility
Beyond the preview
Go deeper on CTR20254476.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20254476.